EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
33 hedge funds and large institutions have $20.2M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
Holders
33
Holders Change
+7
Holders Change %
+26.92%
% of All Funds
0.52%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
10
Increased
3
Reduced
3
Closed
3
Calls
$393K
Puts
$21K
Net Calls
+$372K
Net Calls Change
+$337K
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$731K |
2 |
2
Two Sigma Investments
New York
|
$67.7K |
3 |
HF
3
HRT Financial
New York
|
$25K |
4 |
XT
4
XTX Topco
George Town,
Cayman Islands
|
$23.9K |
5 |
5
Morgan Stanley
New York
|
$14.9K |